The arrival of Retatrutide in the UK is creating significant excitement within the weight management community. This novel dual medication – targeting both GLP-1 and GIP – offers a potentially new approach to tackling weight challenges. Until recently, options have been restricted for many, and Retatrutide represents a hopeful opportunity for p